NexTage Therapeutics
Ramat Gan, IsraelFounded 2019
About NexTage Therapeutics
NexTage Therapeutics is an Israeli biotech developing a proprietary drug delivery platform for cannabinoid-based pharmaceuticals, improving bioavailability and onset time.
Key Facts
- 1Patented lipid-based nanoparticle delivery system increases cannabinoid bioavailability by up to five-fold
- 2Licensed delivery technology to pharmaceutical partners in Europe and North America
Frequently Asked Questions
What problem does NexTage solve?
They solve the poor oral bioavailability of cannabinoids, which typically means only 6-10% of ingested cannabinoids reach the bloodstream.
Do they sell consumer products?
No, they license their drug delivery platform to pharmaceutical companies for use in their own cannabinoid formulations.
Products
- Cannabinoid drug delivery systems
- Bioavailability-enhanced formulations
Specialties
Cannabinoid drug deliveryPharmaceutical bioavailability enhancement
Company Details
- Location
- Ramat Gan, Israel
- Founded
- 2019
- Publicly Traded
- No
Browse all Technology & Equipment
View more companies in this category
Related Companies
More in Israel
Tikun Olam
Tel Aviv \u2014 Medical & Pharma
BOL Pharma
Revadim \u2014 Producer & Grower
InterCure
Herzliya \u2014 Medical & Pharma
Cannbit
Caesarea \u2014 Producer & Grower